Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Open Access
- 25 April 1991
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 324 (17), 1156-1161
- https://doi.org/10.1056/nejm199104253241702
Abstract
Prostate-specific antigen (PSA) is secreted exclusively by prostatic epithelial cells, and its serum concentration is increased in men with prostatic disease, including cancer. We evaluated its usefulness in the detection and staging of prostate cancer.Keywords
This publication has 14 references indexed in Scilit:
- Cancer statistics, 1991CA: A Cancer Journal for Clinicians, 1991
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Nerve-Sparing Radical Prostatectomy: Evaluation of Results after 250 PatientsJournal of Urology, 1990
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the ProstateJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateThe New England Journal of Medicine, 1987
- Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and stagingThe Prostate, 1985
- Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasmsCancer, 1981